SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is drawing attention amid a steep selloff and repeated calls of new lows, with traders debating whether political backlash and midterm concerns are eroding Trump-linked sentiment. Many bears also argue the companys limited operating business leaves the stock dependent on speculative interest, while a smaller group sees a possible bargain or bounce.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Morgan Stanleys designation of Amazon as a top pick, backed by optimism about AWS growth and AI demand, drove the rally. Traders welcomed the upgrade but debated whether gains would hold, with some pointing to resistance and concerns about heavy AI spending ahead of earnings.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBios expanded FDA approval of ANKTIVA for papillary-only bladder cancer is the main catalyst, but the stock has sold off despite the larger eligible patient population and favorable long-term bladder-cancer data. Traders debate whether the decline reflects sell-the-news profit-taking and broader biotech weakness, or concerns about revenue execution and financing; claims of coordinated short-selling remain speculation.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is drawing attention after stronger-than-guided third-quarter results and an upbeat 2027 EBITDA outlook sparked a sharp rally. Bulls point to higher steel pricing and potential short covering, while skeptics question whether the outlook can overcome debt and execution risks.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares are drawing attention amid a steep selloff, with traders pointing to IPO lockup share releases, insider selling, and TD Cowens price-target cut as sources of selling pressure. Bearish voices also question the companys valuation, ability to scale, and reliance on OpenAI, while some investors view the decline as overdone and are buying or averaging down.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS CEO Angelos Stergious 15th-anniversary LinkedIn post has fueled speculation that REGAL Phase 3 results or a corporate development may be approaching, as traders focus on the trials last disclosed count of 78 of 80 events. Bulls read the posts next chapter language as a signal, while skeptics say it was a routine anniversary message and note that the trial remains blinded and no new results are confirmed.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is drawing attention after a sharp pullback alongside semiconductor stocks, with traders debating CEO Hock Tans warnings about capital constraints and speculative AI investment, as well as concerns about AI infrastructure financing. Some view the decline as a buying opportunity given demand for custom AI chips, while others worry that spending and financing risks could weigh on the sector.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is in focus ahead of its quarterly earnings report, with traders watching whether AI- and memory-driven equipment demand will support strong results and guidance. The discussion mixes dip-buying after a steep pullback with caution about valuation, sector volatility, and whether the stock can sustain a rebound.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is drawing attention amid a steep selloff that traders link to weakness across space stocks, SpaceX competition, and delays to NASAs CLPS decisions. The debate is whether the pressure is mainly sector-wide or reflects company-specific concerns about dilution, cash burn, execution, and disappointing results, while some investors see the backlog and future lunar missions as reasons to keep buying.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

Uniteds upcoming quarterly report is the main focus, with traders debating whether resilient travel demand and pricing can offset high fuel costs and support the outlook; some expect a rebound, while others fear earnings or guidance could disappoint. CEO Scott Kirbys inheritance-tax comments have also prompted boycott and sell calls, adding to negative sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS $ABBV $BMY  
 
BAT / Oral Az+VEN Failed to  Increase  Survival in 5 Recent AML Trials  - including Failing  the VIALE-M Phase 3 for CR1 Patients Not  Eligible  for Transplant 
 
You  Know BAT Failed the SLS P3 CONTROL CR2 Patients Not Eligible  for Transplant too.... 
 
it is not complicated. 
 
SLS is worth close to $50B the Instant the IMMINENT Gps Phase 3 Results are Announced.

Captain

BioSwings™

Hawk1979

5,500% ROI this quarter

Brian V

Your trusted analyst

Ulaughing

$SLS $2.158B  $RVMD  
it ain’t BAT causing the miraculous survival we are now seeing in all pooled SLS regal p3 patients.  
 
$ABBV conducted  3 large Phase 3 Trials combining AZ with Venetoclax and they all Failed to Increase Overall Survival for AML Patients  
- Failed to Increase Survival for AML Patients Post Transplant in the VIALE-T Trial and Failed to Increase Survival in First Remission (CR1) VIALE-M Trial. 
 
$MRNA added $55B to its market cap when its  P3 Cancer Vaccine Trial results were announced --- Something  Very SImilar is about to happen here.

StockTwits Web

Revolution Medicines Inc

Abbvie Inc

Moderna Inc

$SLS $2.127B$RVMD $ABBV $MRNA  
This $2.12B Manipulated Equity will be Worth Closer to $50B the Instant the Imminent GPS Phase 3 Results are announced. 
What is Gps worth? 
• 12.5K AML CR2/3 Patients Year 
• 50K AML CR1 Patients Year 
• CO Published Estimated Pricing at $300K Rev Per patient Y1 
• Rev Compounded by infinite dosing regime:  
3 years CR2  
6 year dosing regime on avg. for CR1 
• 300K Patients in Remission Right Now who&#39;ll benefit from Gps right out of the Gate. 
$RVMD set pricing $39,800 per patient per month. $477,600 Y1

Bristol-Myers Squibb Co.

  
 
BAT / Oral Az+VEN Failed to  Increase  Survival in 5 Recent AML Trials  - including Failing  the VIALE-M Phase 3 for CR1 Patients Not  Eligible  for Transplant 
 
You  Know BAT Failed the SLS P3 CONTROL CR2 Patients Not Eligible  for Transplant too.... 
 
it is not complicated. 
 
SLS is worth close to $50B the Instant the IMMINENT Gps Phase 3 Results are Announced.